ROIV compared with IMVT: revenue, margins and what each company keeps, and the suppliers and customers both name

ROIVRoivant Sciences Ltd.

Mkt capRevenueRevenue

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

Compare

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ROIV

0 of 1at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±8.4%▲+1.50%×0.18

May 20 '26—▲+14.89%—

Apr 2 '26—▲+1.76%—

Feb 6 '26—▲+22.14%—

IMVT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±9.0%▲+1.17%×0.13

May 20 '26±15.6%▲+35.26%×2.26

= impliedROIV realized, solidIMVT realized, hatchedOne scale, both sides: full bar = 36%× = |realized| ÷ impliedSource: market data

Feb 6 '26

±13.5%

▲+12.43%

×0.92

Nov 10 '25±16.2%▲+0.09%×0.01

ROIVRoivant Sciences Ltd.

36.90▼−1.65%· post 36.66

Mkt cap$26.7BRevenue$1MQ1 FY26Revenue$8MFY25

IMVTImmunovant, Inc.

29.14▼−1.68%· post 29.57

ClosedOct 30 '26

Mkt cap$6.0BRevenue—Revenue—

Compare

ClosedOct 30 '26

ROIVRoivant Sciences Ltd.

IMVTImmunovant, Inc.

36.90▼−1.65%post 36.66

Price

29.14▼−1.68%post 29.57

$26.7B

Mkt cap

$6.0B

Q1 FY26$1M

Revenue

—

FY25$8M

Revenue

—

ROIV36.90▼−1.65%vsIMVT29.14▼−1.68%ClosedOct 30 '26